0001193125-19-217393 Sample Contracts

X4 PHARMACEUTICALS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt Securities

Indenture • August 9th, 2019 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Indenture
• Filed
  August 9th, 2019
• Company
  X4 Pharmaceuticals, Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

INDENTURE, dated as of , 20 , among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

X4 PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF ___________

Preferred Stock Warrant Agreement • August 9th, 2019 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  August 9th, 2019
• Company
  X4 Pharmaceuticals, Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

X4 PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF _____________

Common Stock Warrant Agreement • August 9th, 2019 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  August 9th, 2019
• Company
  X4 Pharmaceuticals, Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

X4 PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF ______________

Warrant Agreement • August 9th, 2019 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Warrant Agreement
• Filed
  August 9th, 2019
• Company
  X4 Pharmaceuticals, Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).